Blog

RSS Feed
Posted by Michael Wonder on 12 Mar 2019

SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma

11 March 2019 - Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS ...

Read more →
Posted by Michael Wonder on 12 Feb 2019

Yescarta rejected among other SMC decisions

12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...

Read more →
Posted by Michael Wonder on 11 Feb 2019

SMC - February 2019 decisions

11 February 2019 - A medicine used to treat a rare blood cancer in children and young adults has today  ...

Read more →